Bioxytran (BIXT) Other Non-Current Assets (2012)

Bioxytran (BIXT) posted Other Non-Current Assets of -$15633.0 for Q4 2012.

Bioxytran (BIXT) Other Non-Current Assets (2012) Analysis & Trends

Bioxytran has reported Other Non-Current Assets for 1 years, with the latest figure at -$15633.0 in Q4 2012.

Quarterly Other Non-Current Assets changed N/A year-over-year to -$15633.0 in Q4 2012, while the trailing twelve-month figure through Dec 2012 was -$15633.0 (changed N/A YoY) and the FY2012 annual result came in at -$15633.0, changed N/A from the prior year.
Other Non-Current Assets was little changed at -$15633.0 in Q4 2012 per BIXT's latest filing.
Over five years, Other Non-Current Assets peaked at -$15633.0 in Q4 2012 and troughed at -$15633.0 in Q4 2012.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Vertex Pharmaceuticals	138.81 Bn	130.96 Bn	2.84 Bn	1.25 Bn
2	Regeneron Pharmaceuticals	86.07 Bn	78.08 Bn	3.93 Bn	2.31 Bn
3	Argenx Se	65.47 Bn	60.29 Bn	1.37 Bn	124.00 Mn
4	Moderna	55.64 Bn	50.50 Bn	52.00 Mn	618.00 Mn
5	BeOne Medicines	41.99 Bn	36.89 Bn	1.53 Bn	109.58 Mn
6	Alnylam Pharmaceuticals	31.68 Bn	28.37 Bn	992.69 Mn	65.13 Mn
7	BioNTech SE	27.69 Bn	9.29 Bn	668.28 Mn	202.31 Mn
8	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	104.44 Mn
9	Royalty Pharma	27.36 Bn	26.52 Bn	-	62.96 Mn
10	Bioxytran	2.52 Mn	2.27 Mn	-	-

Download Data

Date	Value
Dec 31, 2012	-15,633.00